Patiromer Calcium Sorbitex
Brand name: Veltassa
Rank #277 of 500 drugs by total cost
$43.4M
Total Cost
40,534
Total Claims
$43.4M
Total Cost
1,598
Prescribers
$1,070
Cost per Claim
4,592
Beneficiaries
49,834
30-Day Fills
$27K
Avg Cost/Provider
25
Avg Claims/Provider
About Patiromer Calcium Sorbitex
Patiromer Calcium Sorbitex (sold as Veltassa) was prescribed 40,534 times by 1,598 Medicare Part D providers in 2023, costing the program $43.4M. At $1,070 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 274 | Finasteride (Finasteride) | $44.6M | 2,766,115 |
| 275 | Baclofen (Baclofen) | $44.2M | 1,916,226 |
| 276 | Fluoxetine Hcl (Fluoxetine Hcl) | $43.9M | 2,891,768 |
| 277 | Patiromer Calcium Sorbitex (Veltassa) | $43.4M | 40,534 |
| 278 | Hydralazine Hcl (Hydralazine Hcl) | $43.2M | 2,256,779 |
| 279 | Leuprolide Acetate (Lupron Depot) | $42.7M | 9,949 |
| 280 | Efgartigimod Alfa-Fcab (Vyvgart) | $42.6M | 1,005 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology